Completed PHASE1 INTERVENTIONAL 4-arm NCT00773630

A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions

Sponsor: Otsuka Frankfurt Research Institute GmbH

Interventions Cilostazol

Updated 5 times since 2017 Last updated: Sep 8, 2011 Started: Dec 31, 2008 Primary completion: Mar 31, 2009 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00773630, this PHASE1 trial focuses on Intermittent Claudication and remains completed. Sponsored by Otsuka Frankfurt Research Institute GmbH, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Otsuka Frankfurt Research Institute GmbH

Data source: Otsuka Frankfurt Research Institute GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Neu-Ulm, Germany